Dianthus Therapeutics (DNTH) Profit After Tax Growth (3y) (2020 - 2025)
Dianthus Therapeutics (DNTH) Profit After Tax Growth (3y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 6.30% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.23% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 91.31% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 37.89% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 90.66% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -38.56% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 37.44% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 59.34% |
| 10 | Dianthus Therapeutics | 4.97 Bn | 4.57 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -66.72% |
| Jun 30, 2025 | -77.09% |
| Mar 31, 2025 | -82.18% |
| Dec 31, 2024 | -13.84% |
| Sep 30, 2024 | -13.04% |
| Jun 30, 2024 | -1.31% |
| Mar 31, 2024 | 7.71% |
| Dec 31, 2023 | 16.49% |
| Sep 30, 2023 | 6.03% |
| Jun 30, 2023 | 16.72% |
| Mar 31, 2023 | 29.24% |
| Dec 31, 2022 | 24.18% |
| Sep 30, 2022 | 27.76% |
| Jun 30, 2022 | 31.49% |
| Mar 31, 2022 | 30.96% |
| Dec 31, 2021 | -4.98% |
| Sep 30, 2021 | -2.86% |
| Jun 30, 2021 | -7.43% |
| Mar 31, 2021 | -16.15% |
| Dec 31, 2020 | -31.32% |